IL17A and melanoma: Notably, DTH immune response correlated with a marked reduction in the frequency of regulatory T (Treg) cells and an increase in the proportion of T cells producing IFN-γ (Th1) and interleukin (IL)-17 (Th17) in the peripheral blood of DTHpos melanoma patients [11,13].